Evan Loh

Physician, father, and drug developer focused on bringing new antibiotics to physicians and patients

[Evan Loh @EvanLohMD]

Strong public-private partnerships are critical for national security & the significant impact of leveraging private sector expertise in antimicrobials to advance preparedness and response capabilities is clear. Paratek looks forward to being a part of this effort. #PublicHealth

[Paratek @ParatekPharma]

Celebrating 20 years of @BARDA's #ProjectBioShield!

Paratek is proud to honor this milestone and highlight our partnership with BARDA's #ProjectBioShield, a vital collaboration to advance national preparedness against biological threats. #Biosecurity

[Evan Loh @EvanLohMD]

Agree w/ experts on strengthening the #antibiotic pipeline by addressing market failures & boosting investments to ensure success across the value chain, incl. commercialization needs. Encouraged by this & other strategies to combat #AMR from GLG on AMR. https://t.co/c7HAapqCY6

[Evan Loh @EvanLohMD]

Given mounting geopolitical tensions, we need to be more concerned about our country's #supplychain for critical medicines. To echo @JohnFCrowley, “The consequences of having critical manufacturing offshore are clear… we have to be prepared.” #antibiotics #biotech

[Biotechnology Innovation Organization @IAmBiotech]

A recently released Defense Department report “identified that 54% of the DoD pharmaceutical supply chain is considered either high or very high risk, with dependency on non-Trade Agreements Act (TAA) compliant suppliers, sourcing from China and India, or unknown.” https://t.co/ow1TUeKeTg

[Evan Loh @EvanLohMD]

Disheartened to read about declining number of scientists w/ #AMR expertise in the @AMRAlliance report. Public-private partnerships, such as the Paratek-BARDA partnership, are a way to support new research for innovative #antimicrobials. https://t.co/Ldk4DMnsdG

[AMR IndustryAlliance @AMRAlliance]

Despite AMR ranking as a top 10 global health threat by the WHO, there were 35 times more papers published on cancer than priority bacteria and 20 times more patents awarded for cancer than antibiotics in 2022.

[Evan Loh @EvanLohMD]

Congratulations Jonathan Light and Christopher Bostrom. I look forward to continuing to partner with you as we advance Paratek's growth strategy.

[Paratek @ParatekPharma]

We’re celebrating the promotions of Jonathan Light to General Counsel, Corporate Secretary and Chief Compliance Officer and Christopher Bostrom to Chief Financial Officer. Please join us in congratulating them! And you can learn more at: https://t.co/VBMkm6GVh2

[Evan Loh @EvanLohMD]

Looking forward to a robust discussion tomorrow (Jan. 18) as I join other industry leaders to preview the @IAmBiotech CEO & Investor Conference & talk about how BIO’s 1:1 Partnering can help you make progress against your ‘24 business goals. Register for the webinar⤵️ #BIOCEO24

[Biotechnology Innovation Organization @IAmBiotech]

Join us on January 18 for a FREE webinar that will preview the program for the BIO CEO & Investor Conference and explain how BIO’s One-on-One Partnering during the event can help you make progress against your 2024 priorities. #BIOCEO24

https://t.co/nC9vnOSnYR

[Evan Loh @EvanLohMD]

Lots to consider here as @BillGates explains why 2024 could shape our world for years. Particularly intrigued by the potential of #AI as a vehicle to help combat #AMR. Read more about this research & other innovations shaping our world in the Gates Report: https://t.co/VS4DzcBPVN

[Evan Loh @EvanLohMD]

Insightful read from @AJack of the @FT, examining how war is spreading disease and escalating #AMR globally. Government leaders must improve access to novel #antibiotics to help protect against this material threat. https://t.co/I21aFefYt9

[Evan Loh @EvanLohMD]

More #AMR funding is always good news however it's not enough to fix the industry. Gov’t must support a marketplace that incentivizes innovation & requires new regulatory, policy & reimbursement pathways to create viable access models for new #antibiotics. https://t.co/h8tw8kjLkr

[Evan Loh @EvanLohMD]

Check out @dmosbergen's @WSJ article on the business of #antibiotics. I'm proud of Paratek's success in a challenging marketplace. However, if we don't modernize today's reimbursement system, the innovation curve for antibiotics will continue to crater. https://t.co/bFuGrNls5R

[Evan Loh @EvanLohMD]

Thank you @Laura_H for featuring my views on the Diagnosis Related Group (DRG) system & why #Medicare needs to modernize its approach & create a separate payment system that recognizes the value of novel, life-saving antibiotics. https://t.co/CfDHwKc3KS

#AntimicrobialResistance

[Evan Loh @EvanLohMD]

Glad to be part of the important discussion during the @DukeMargolis #AMR webinar. The solution is complex & requires the involvement of the entire U.S. Gov’t & w/out legislative engagement there will be no progress. More about the solutions discussed: https://t.co/McBlxtAfL5

[Evan Loh @EvanLohMD]

Another big pharma cutting infectious disease R&D as viral and bacterial infections threaten national security and global health more than ever. Read about Janssen's plans: https://t.co/XaqRPuPObN #AMR

[Evan Loh @EvanLohMD]

There’s still time to register for tomorrow’s 1 pm @DukeMargolis webinar. I’ll join other experts to discuss the threat viral and bacterial infections pose for national security, global public health and the economy. Don’t miss it. Register here: https://t.co/5ziH0IxJiR #AMR

[Evan Loh @EvanLohMD]

Proud to join this impressive group - Mark McClellan, MD, PhD, Lynn Filpi, @Payal_Patel & @JohnRex_NewAbx - for an incredibly important @DukeMargolis webinar examining what can be done to advance #pandemic preparedness in the face of viral & bacterial threats. Register ⤵️ #AMR

[Duke-Margolis @DukeMargolis]

How can we best prepare to combat infectious diseases and drug-resistant bacterial threats? Learn more about this topic from a policy perspective during our upcoming webinar on August 29.

Register here: https://t.co/C1UxwjCKKc

[Evan Loh @EvanLohMD]

Outstanding article by @kweintraub and @AdriannaUSAT on the current state of #antibiotics and what can be done to solve #AMR. One more way to ensure antibiotics are available is modernizing reimbursement to recognize the value of life-saving antibiotics. https://t.co/ZsUIaC2ir9

[Evan Loh @EvanLohMD]

As the threat of #AntibioticResistance continues to increase, these types of stories will become more common. We all need to work together to change the trajectory of #AMR. https://t.co/lY2mel63YF

[Evan Loh @EvanLohMD]

Thank you @DonnaShalala @liliabbo and Dr. Mark McClellan for highlighting the complexities of #AMR and how it impacts patients while calling for the federal government to work quickly to change the marketplace dynamics. https://t.co/fWERnjkIUs #PASTEURAct #DISARMAct

[Evan Loh @EvanLohMD]

Thanks to all who worked to reintroduce the #PASTEURAct. This legislation + other steps to modernize reimbursement for newer #antibiotics are key to saving lives and our essential industry of innovators. Learn more: https://t.co/ZhVgtzgsHX #AntimicrobialResistance #AMR

[Evan Loh @EvanLohMD]

Growing the #antibiotics pipeline to address global need is essential yet requires new regulatory, policy & pricing pathways to create viable economic models for new #antibiotics, as @CidsIndia President Dr. Venkatasubramanian Ramasubramanian suggests. https://t.co/4HeFpgHwBP